FLORIO, PIER PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.955
EU - Europa 723
AS - Asia 216
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 3.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.951
IE - Irlanda 290
IT - Italia 155
SE - Svezia 142
CN - Cina 104
RU - Federazione Russa 96
SG - Singapore 56
HK - Hong Kong 50
GB - Regno Unito 15
CH - Svizzera 8
DE - Germania 6
JO - Giordania 5
CA - Canada 4
NL - Olanda 4
UA - Ucraina 4
EU - Europa 3
BO - Bolivia 2
FR - Francia 2
GR - Grecia 1
TR - Turchia 1
Totale 3.899
Salva come PNG Salva come JPEG
Città #
Fairfield 659
Seattle 297
Ashburn 294
Dublin 290
Woodbridge 287
Houston 240
Cambridge 217
Wilmington 194
Altamura 142
Lawrence 140
Buffalo 71
Princeton 71
Boston 66
Chandler 62
Ann Arbor 56
Beijing 46
Singapore 40
San Diego 26
Kent 18
Shanghai 17
Falls Church 14
Medford 13
Norwalk 13
Andover 10
Hillsboro 10
Bern 8
Redmond 5
Bremen 4
Toronto 4
Boardman 3
Coreno Ausonio 3
Guangzhou 3
Kilburn 3
Laurel 3
Shenzhen 3
Aversa 2
Chiswick 2
Cochabamba 2
Florence 2
Foshan 2
Jacksonville 2
London 2
New Bedfont 2
Torrevecchia Pia 2
Arnsberg 1
Castelfranco Veneto 1
Cedar Knolls 1
Dongyang 1
Heze 1
Hounslow 1
Islington 1
Izmir 1
Jiaxing 1
Jinhua 1
Milan 1
Nantong 1
Padova 1
Paris 1
Philadelphia 1
Quanzhou 1
Rui'an 1
Shaoxing 1
Tiantai Chengguanzhen 1
Tongchuanshi 1
Trumbull 1
Wijchen 1
Wuhan 1
Totale 3.373
Salva come PNG Salva come JPEG
Nome #
Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor 93
Corticotropin-releasing factor-binding protein: Origins and possible functions 89
Abnormal umbilical artery Doppler waveforms and cord blood inhibin A and inhibin B levels 85
Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: Effect of prostaglandin administration 82
Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery 81
Increased midtrimester amniotic fluid activin A: A risk factor for subsequent fetal death 80
The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia 77
Abruptio placentae and highest maternal serum activin a levels at mid-gestation: A two cases report 77
Maternal plasma calcitonin gene-related peptide levels do not change during labor and are not influenced by delivery route 74
Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women 74
Corticotropin-releasing hormone facilitates early survival of discordant (bovine-to-rat) islet xenografts 74
Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro 73
Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour 72
Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy 72
Changes in inhibins and activin secretion in healthy and pathological pregnancies 72
Hypertension in pregnancy: Changes in activin a maternal serum concentration 70
Activin A stimulates insulin secretion in cultured human pancreatic islets 70
Placental stress factors and human parturition 68
Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA 68
Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases 67
Local production and action of follistatin in human placenta 66
Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage 65
Maternal decidua and fetal membranes contain immunoreactive neuropeptide Y 65
Corticotropin-releasing factor and its binding protein: Maternal serum levels in term and preterm deliveries 65
Human placental corticotropin-releasing factor (CRF) in the adaptive response to pregnancy 64
Stress and pregnancy: CRF as biochemical marker 64
High serum follistatin levels in women with ovarian endometriosis 64
High Levels of Intrauterine Corticotrophin-Releasing Hormone, Urocortin, Tryptase, and Interleukin-8 in Spontaneous Abortions 62
Cervical ripening and induction of labor by prostaglandin E2: A comparison between intracervical gel and vaginal pessary 62
Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle 61
Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation 61
High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension 61
Thickness of fetal membranes: A possible ultrasound marker for preterm delivery 59
Prediction of successful induction of labor at term: Role of clinical history, digital examination, ultrasound assessment of the cervix, and fetal fibronectin assay 59
Placental Neurokinin B mRNA Expression Increases at Preterm Labor 59
Effect of acute corticotropin releasing factor on pituitary-adrenocortical responsiveness in elderly women and men 57
Placental expression of substance P and vasoactive intestinal peptide: Evidence for a local effect on hormone release 56
Secretory endometrium highly expresses urocortin messenger RNA and peptide: Possible role in the decidualization process 56
Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol 55
Corticotropin-releasing factor, urocortin and endothelian-1 stimulate activin A release from cultured human placental cells 55
null 54
High fetal urocortin levels at term and preterm labor 54
Inhibins and activins in pregnancy 53
Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes 53
The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia 52
Activin A, inhibin A, inhibin B and parturition: Changes of maternal and cord serum levels according to the mode of delivery 51
High levels of serum allopregnanolone in women with premature ovarian failure 50
Activin A, corticotropin-releasing factor and prostaglandin F(2α) increase immunoreactive oxytocin release from cultured human placental cells 50
Human placenta and fetal membranes express nerve growth factor mRNA and protein 49
Expression and secretion of activin A: Possible physiological and clinical implications 49
Cerebrospinal Fluid Activin A Measurement in Asphyxiated Full-Term Newborns Predicts Hypoxic Ischemic Encephalopathy 48
Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein 46
Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women 45
Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women 44
Human placenta and fetal membranes express follistatin-related gene mRNA and protein 43
Mutational analysis of the inhibin alpha gene in preeclamptic women 43
Pre-eclampsia with fetal growth restriction: Placental and serum activin A and inhibin A levels 42
Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy 42
Serum activin A levels in males and females during pubertal development 37
Paracrine/autocrine control of female reproduction 36
Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal pathological pregnancies 34
Activin A and activin B measured in maternal serum, cord blood serum and amniotic fluid during human pregnancy 34
Postmenopause is associated with a decrease in serum inhibin A and inhibin B levels but not in activin A 28
La miomectomia per via laparoscopica: Confronto tra elettrochirurgia e bisturi ad ultrasuoni 28
Stress und Frühgeburt Neuroendokriner Hintergrund von akutem und chronischem Stress als Auslöser für eine Frühgeburt 27
High levels of fetal membrane activin βA and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor 24
Lack of gestation-related changes of urocortin gene expression in human placenta 23
The detection of anti-β2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester 23
Esteroides en el embarazo 21
Human GnRH-secreting cultured neurons express activin βA subunit mRNA and secrete dimeric activin A 21
Parturition in two pregnant women with Addison's disease: Changes of plasma corticotropin releasing factor levels 17
Activins and related proteins in the establishment of pregnancy 14
Fetal neural tube defects: Maternal serum and amniotic fluid activin A levels 9
Totale 3.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.440 0 133 8 104 234 206 188 179 183 96 76 33
2020/2021419 65 40 10 71 29 7 1 8 82 13 87 6
2021/2022545 20 77 61 9 16 11 43 20 12 17 110 149
2022/2023919 110 302 40 27 16 134 174 23 45 12 23 13
2023/2024210 9 22 75 5 19 30 10 7 4 0 20 9
2024/2025198 167 31 0 0 0 0 0 0 0 0 0 0
Totale 3.978